Alzheimers is a kind of dementia that leads to memory loss accompanied by a problem in the behavior process and thinking ability of an individual. Alzheimers is a progressive disease, and it steadily increases over time and damages the maximum part of the brain, finally destroying brain cells. Due to this disease, the patient has abnormal brain function that affects their memory, thinking, behavior, judgment, and language. Repetitive movements, memory loss, insomnia, agitation, anxiety, depression, and loss of reasoning abilities are some of the symptoms of Alzheimers disease. This disease typically progresses from mild to moderate to severe stage. There is not a single diagnostic test that can determine if the person has this condition. Physicians, usually with the help of specialists such as neurologists, neuropsychologists, geriatricians, and geriatric psychiatrists, use various approaches and tools to help make a diagnosis.
MARKET DYNAMICS
Alzheimers disease diagnostic market has shown a significant evolution over the forecast period. The rise of the Alzheimers disease diagnostic market is majorly driven by the rising prevalence of chronic diseases like dementia, investment in biomarkers for drug development, and growing sophisticated diagnostics for the early detection of the disease. Alzheimers disease is one of the most frequently occurring types of dementia that occurs globally. According to the Alzheimers net, about 50 million people have Alzheimers or related dementia. The development of clinical diagnostics for Alzheimers disease (AD) and other neurodegenerative conditions is becoming very important. Specific biomarkers that may improve the accuracy of the diagnosis are used. Also, factors such as rising healthcare costs, growing accident injuries causing brain harm, shifting habits, and a tendency towards a sedentary lifestyle are generating tremendous demand in the industry. However, insufficient knowledge of the signs of the disease and the availability of diagnostic procedures are key factors that hinder market development.
MARKET SCOPE
The "Alzheimers Disease Diagnostic Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry's medical device, with a specific focus on the global market trend analysis. This report provides an outline of the Alzheimers disease diagnostic market with detailed market segmentation by type, diagnostic testing, and end-user. Alzheimers disease diagnostic market is estimated to witness high growth during the forecast period. It focuses on the vital statistics on the leading players' market status in the Alzheimers disease diagnostic market and offers key opportunities and trends in the market.
MARKET SEGMENTATION
The market is categorized based on the type, diagnostic testing, and end user. Based on the type, the market is segmented as early-onset Alzheimers, late-onset Alzheimers, and familial Alzheimers diseases. Based on the diagnostic testing, the segmentation of the market is into genetic testing, mini-mental state exam (MMSE), neurological exam, brain imaging, and others. Based on end user, segmentation of the market is into hospitals and clinics, diagnostic centers and research institutes, and others.
REGIONAL FRAMEWORK
The report states a detailed outline of the industry, consisting of both qualitative and quantitative information. It gives a sketch and forecast of the Alzheimers disease diagnostic market based on various segments. The report also comprises market size and forecast estimates from the year 2021 to2031with respect to five primary regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East, and Africa (MEA), and South & Central America (SCAM). The Alzheimers disease diagnostic market by each region is then sub-segmented into respective countries and segments. It provides the analysis and forecast of 18 countries worldwide and the recent trend and opportunities prevailing in the region.
The report analyzes factors affecting the Alzheimers disease diagnostic market from both the demand and supply sides. Moreover, it evaluates market dynamics regarding the market during the forecast period, i.e., drivers, restraints, opportunities, and future trends. It also comprises a precise PEST analysis for all five regions, namely, North America, APAC, Europe, MEA, and South & Central America, after assessing political, social, economic, and technological factors affecting the Alzheimers disease diagnostic market in these regions.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report states a detailed outline of the industry, consisting of both qualitative and quantitative information. It gives a sketch and forecast of the Alzheimers disease diagnostic market based on various segments. The report also comprises market size and forecast estimates from the year 2021 to2031with respect to five primary regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East, and Africa (MEA), and South & Central America (SCAM). The Alzheimers disease diagnostic market by each region is then sub-segmented into respective countries and segments. It provides the analysis and forecast of 18 countries worldwide and the recent trend and opportunities prevailing in the region.
The report analyzes factors affecting the Alzheimers disease diagnostic market from both the demand and supply sides. Moreover, it evaluates market dynamics regarding the market during the forecast period, i.e., drivers, restraints, opportunities, and future trends. It also comprises a precise PEST analysis for all five regions, namely, North America, APAC, Europe, MEA, and South & Central America, after assessing political, social, economic, and technological factors affecting the Alzheimers disease diagnostic market in these regions.
MARKET PLAYERS
The report contains critical developments in the Alzheimers disease diagnostic market as inorganic and organic growth strategies. Multiple companies are pivoting on organic growth strategies like product approvals, product launches, and others, such as patents and events. Inorganic growth strategies noticed in the market were collaborations and acquisitions & partnerships. Many such activities have paved the path for the elaboration of the business and customer base of market players. The market players from the Alzheimers disease diagnostic market are estimated to have profitable growth opportunities in the coming years with the growing demand for Alzheimers disease diagnostic in the global market. Mentioned below is the list of a few companies engaged in the Alzheimers disease diagnostic market.
The report also provides key players' profiles in the Alzheimers disease diagnostic market, along with their SWOT analysis and market strategies. Moreover, the report focuses on the key market players with information on company profiles, financial information of the last three years, components, and services provided, critical development in the past five years.
- Abbvie Inc.
- TauRx Pharmaceuticals Ltd
- Eli Lilly and Company.
- Alector, Inc.
- Treventis Corporation.
- Accera, Inc.
- Cognition Therapeutics, Inc.
- Biogen
- F. Hoffmann-La Roche Ltd
- Amarantus BioScience Holdings, Inc.
The Insight Partner's dedicated research and the analytical team consists of experienced professionals with advanced statistical expertise and provides various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Alzheimers Disease Diagnostic Market - By Type
1.3.2 Alzheimers Disease Diagnostic Market - By Diagnostic Testing
1.3.3 Alzheimers Disease Diagnostic Market - By End User
1.3.4 Alzheimers Disease Diagnostic Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ALZHEIMER'S DISEASE DIAGNOSTIC MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS
5. ALZHEIMER'S DISEASE DIAGNOSTIC MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ALZHEIMER'S DISEASE DIAGNOSTIC MARKET - GLOBAL MARKET ANALYSIS
6.1. ALZHEIMER'S DISEASE DIAGNOSTIC - GLOBAL MARKET OVERVIEW
6.2. ALZHEIMER'S DISEASE DIAGNOSTIC - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ALZHEIMER'S DISEASE DIAGNOSTIC MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. EARLY-ONSET ALZHEIMER'S
7.3.1. Overview
7.3.2. Early-onset Alzheimers Market Forecast and Analysis
7.4. LATE-ONSET ALZHEIMER'S
7.4.1. Overview
7.4.2. Late-onset Alzheimers Market Forecast and Analysis
7.5. FAMILIAL ALZHEIMER'S DISEASES
7.5.1. Overview
7.5.2. Familial Alzheimers Diseases Market Forecast and Analysis
8. ALZHEIMER'S DISEASE DIAGNOSTIC MARKET - REVENUE AND FORECASTS TO 2028 - DIAGNOSTIC TESTING
8.1. OVERVIEW
8.2. DIAGNOSTIC TESTING MARKET FORECASTS AND ANALYSIS
8.3. GENETIC TESTING
8.3.1. Overview
8.3.2. Genetic Testing Market Forecast and Analysis
8.4. NEUROLOGICAL EXAM
8.4.1. Overview
8.4.2. Neurological Exam Market Forecast and Analysis
8.5. MINI-MENTAL STATE EXAM (MMSE)
8.5.1. Overview
8.5.2. Mini-mental State Exam (MMSE) Market Forecast and Analysis
8.6. BRAIN IMAGING
8.6.1. Overview
8.6.2. Brain Imaging Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. ALZHEIMER'S DISEASE DIAGNOSTIC MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS & CLINICS
9.3.1. Overview
9.3.2. Hospitals & Clinics Market Forecast and Analysis
9.4. DIAGNOSTIC CENTERS AND RESEARCH INSTITUTES
9.4.1. Overview
9.4.2. Diagnostic Centers and Research Institutes Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis
10. ALZHEIMER'S DISEASE DIAGNOSTIC MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Alzheimers Disease Diagnostic Market Overview
10.1.2 North America Alzheimers Disease Diagnostic Market Forecasts and Analysis
10.1.3 North America Alzheimers Disease Diagnostic Market Forecasts and Analysis - By Type
10.1.4 North America Alzheimers Disease Diagnostic Market Forecasts and Analysis - By Diagnostic Testing
10.1.5 North America Alzheimers Disease Diagnostic Market Forecasts and Analysis - By End User
10.1.6 North America Alzheimers Disease Diagnostic Market Forecasts and Analysis - By Countries
10.1.6.1 United States Alzheimers Disease Diagnostic Market
10.1.6.1.1 United States Alzheimers Disease Diagnostic Market by Type
10.1.6.1.2 United States Alzheimers Disease Diagnostic Market by Diagnostic Testing
10.1.6.1.3 United States Alzheimers Disease Diagnostic Market by End User
10.1.6.2 Canada Alzheimers Disease Diagnostic Market
10.1.6.2.1 Canada Alzheimers Disease Diagnostic Market by Type
10.1.6.2.2 Canada Alzheimers Disease Diagnostic Market by Diagnostic Testing
10.1.6.2.3 Canada Alzheimers Disease Diagnostic Market by End User
10.1.6.3 Mexico Alzheimers Disease Diagnostic Market
10.1.6.3.1 Mexico Alzheimers Disease Diagnostic Market by Type
10.1.6.3.2 Mexico Alzheimers Disease Diagnostic Market by Diagnostic Testing
10.1.6.3.3 Mexico Alzheimers Disease Diagnostic Market by End User
10.2. EUROPE
10.2.1 Europe Alzheimers Disease Diagnostic Market Overview
10.2.2 Europe Alzheimers Disease Diagnostic Market Forecasts and Analysis
10.2.3 Europe Alzheimers Disease Diagnostic Market Forecasts and Analysis - By Type
10.2.4 Europe Alzheimers Disease Diagnostic Market Forecasts and Analysis - By Diagnostic Testing
10.2.5 Europe Alzheimers Disease Diagnostic Market Forecasts and Analysis - By End User
10.2.6 Europe Alzheimers Disease Diagnostic Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Alzheimers Disease Diagnostic Market
10.2.6.1.1 Germany Alzheimers Disease Diagnostic Market by Type
10.2.6.1.2 Germany Alzheimers Disease Diagnostic Market by Diagnostic Testing
10.2.6.1.3 Germany Alzheimers Disease Diagnostic Market by End User
10.2.6.2 France Alzheimers Disease Diagnostic Market
10.2.6.2.1 France Alzheimers Disease Diagnostic Market by Type
10.2.6.2.2 France Alzheimers Disease Diagnostic Market by Diagnostic Testing
10.2.6.2.3 France Alzheimers Disease Diagnostic Market by End User
10.2.6.3 Italy Alzheimers Disease Diagnostic Market
10.2.6.3.1 Italy Alzheimers Disease Diagnostic Market by Type
10.2.6.3.2 Italy Alzheimers Disease Diagnostic Market by Diagnostic Testing
10.2.6.3.3 Italy Alzheimers Disease Diagnostic Market by End User
10.2.6.4 Spain Alzheimers Disease Diagnostic Market
10.2.6.4.1 Spain Alzheimers Disease Diagnostic Market by Type
10.2.6.4.2 Spain Alzheimers Disease Diagnostic Market by Diagnostic Testing
10.2.6.4.3 Spain Alzheimers Disease Diagnostic Market by End User
10.2.6.5 United Kingdom Alzheimers Disease Diagnostic Market
10.2.6.5.1 United Kingdom Alzheimers Disease Diagnostic Market by Type
10.2.6.5.2 United Kingdom Alzheimers Disease Diagnostic Market by Diagnostic Testing
10.2.6.5.3 United Kingdom Alzheimers Disease Diagnostic Market by End User
10.2.6.6 Rest of Europe Alzheimers Disease Diagnostic Market
10.2.6.6.1 Rest of Europe Alzheimers Disease Diagnostic Market by Type
10.2.6.6.2 Rest of Europe Alzheimers Disease Diagnostic Market by Diagnostic Testing
10.2.6.6.3 Rest of Europe Alzheimers Disease Diagnostic Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Alzheimers Disease Diagnostic Market Overview
10.3.2 Asia-Pacific Alzheimers Disease Diagnostic Market Forecasts and Analysis
10.3.3 Asia-Pacific Alzheimers Disease Diagnostic Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Alzheimers Disease Diagnostic Market Forecasts and Analysis - By Diagnostic Testing
10.3.5 Asia-Pacific Alzheimers Disease Diagnostic Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Alzheimers Disease Diagnostic Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Alzheimers Disease Diagnostic Market
10.3.6.1.1 Australia Alzheimers Disease Diagnostic Market by Type
10.3.6.1.2 Australia Alzheimers Disease Diagnostic Market by Diagnostic Testing
10.3.6.1.3 Australia Alzheimers Disease Diagnostic Market by End User
10.3.6.2 China Alzheimers Disease Diagnostic Market
10.3.6.2.1 China Alzheimers Disease Diagnostic Market by Type
10.3.6.2.2 China Alzheimers Disease Diagnostic Market by Diagnostic Testing
10.3.6.2.3 China Alzheimers Disease Diagnostic Market by End User
10.3.6.3 India Alzheimers Disease Diagnostic Market
10.3.6.3.1 India Alzheimers Disease Diagnostic Market by Type
10.3.6.3.2 India Alzheimers Disease Diagnostic Market by Diagnostic Testing
10.3.6.3.3 India Alzheimers Disease Diagnostic Market by End User
10.3.6.4 Japan Alzheimers Disease Diagnostic Market
10.3.6.4.1 Japan Alzheimers Disease Diagnostic Market by Type
10.3.6.4.2 Japan Alzheimers Disease Diagnostic Market by Diagnostic Testing
10.3.6.4.3 Japan Alzheimers Disease Diagnostic Market by End User
10.3.6.5 South Korea Alzheimers Disease Diagnostic Market
10.3.6.5.1 South Korea Alzheimers Disease Diagnostic Market by Type
10.3.6.5.2 South Korea Alzheimers Disease Diagnostic Market by Diagnostic Testing
10.3.6.5.3 South Korea Alzheimers Disease Diagnostic Market by End User
10.3.6.6 Rest of Asia-Pacific Alzheimers Disease Diagnostic Market
10.3.6.6.1 Rest of Asia-Pacific Alzheimers Disease Diagnostic Market by Type
10.3.6.6.2 Rest of Asia-Pacific Alzheimers Disease Diagnostic Market by Diagnostic Testing
10.3.6.6.3 Rest of Asia-Pacific Alzheimers Disease Diagnostic Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Alzheimers Disease Diagnostic Market Overview
10.4.2 Middle East and Africa Alzheimers Disease Diagnostic Market Forecasts and Analysis
10.4.3 Middle East and Africa Alzheimers Disease Diagnostic Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Alzheimers Disease Diagnostic Market Forecasts and Analysis - By Diagnostic Testing
10.4.5 Middle East and Africa Alzheimers Disease Diagnostic Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Alzheimers Disease Diagnostic Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Alzheimers Disease Diagnostic Market
10.4.6.1.1 South Africa Alzheimers Disease Diagnostic Market by Type
10.4.6.1.2 South Africa Alzheimers Disease Diagnostic Market by Diagnostic Testing
10.4.6.1.3 South Africa Alzheimers Disease Diagnostic Market by End User
10.4.6.2 Saudi Arabia Alzheimers Disease Diagnostic Market
10.4.6.2.1 Saudi Arabia Alzheimers Disease Diagnostic Market by Type
10.4.6.2.2 Saudi Arabia Alzheimers Disease Diagnostic Market by Diagnostic Testing
10.4.6.2.3 Saudi Arabia Alzheimers Disease Diagnostic Market by End User
10.4.6.3 U.A.E Alzheimers Disease Diagnostic Market
10.4.6.3.1 U.A.E Alzheimers Disease Diagnostic Market by Type
10.4.6.3.2 U.A.E Alzheimers Disease Diagnostic Market by Diagnostic Testing
10.4.6.3.3 U.A.E Alzheimers Disease Diagnostic Market by End User
10.4.6.4 Rest of Middle East and Africa Alzheimers Disease Diagnostic Market
10.4.6.4.1 Rest of Middle East and Africa Alzheimers Disease Diagnostic Market by Type
10.4.6.4.2 Rest of Middle East and Africa Alzheimers Disease Diagnostic Market by Diagnostic Testing
10.4.6.4.3 Rest of Middle East and Africa Alzheimers Disease Diagnostic Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Alzheimers Disease Diagnostic Market Overview
10.5.2 South and Central America Alzheimers Disease Diagnostic Market Forecasts and Analysis
10.5.3 South and Central America Alzheimers Disease Diagnostic Market Forecasts and Analysis - By Type
10.5.4 South and Central America Alzheimers Disease Diagnostic Market Forecasts and Analysis - By Diagnostic Testing
10.5.5 South and Central America Alzheimers Disease Diagnostic Market Forecasts and Analysis - By End User
10.5.6 South and Central America Alzheimers Disease Diagnostic Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Alzheimers Disease Diagnostic Market
10.5.6.1.1 Brazil Alzheimers Disease Diagnostic Market by Type
10.5.6.1.2 Brazil Alzheimers Disease Diagnostic Market by Diagnostic Testing
10.5.6.1.3 Brazil Alzheimers Disease Diagnostic Market by End User
10.5.6.2 Argentina Alzheimers Disease Diagnostic Market
10.5.6.2.1 Argentina Alzheimers Disease Diagnostic Market by Type
10.5.6.2.2 Argentina Alzheimers Disease Diagnostic Market by Diagnostic Testing
10.5.6.2.3 Argentina Alzheimers Disease Diagnostic Market by End User
10.5.6.3 Rest of South and Central America Alzheimers Disease Diagnostic Market
10.5.6.3.1 Rest of South and Central America Alzheimers Disease Diagnostic Market by Type
10.5.6.3.2 Rest of South and Central America Alzheimers Disease Diagnostic Market by Diagnostic Testing
10.5.6.3.3 Rest of South and Central America Alzheimers Disease Diagnostic Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ALZHEIMER'S DISEASE DIAGNOSTIC MARKET, KEY COMPANY PROFILES
12.1. ABBVIE INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. TAURX PHARMACEUTICALS LTD
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ELI LILLY AND COMPANY.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ALECTOR, INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. TREVENTIS CORPORATION.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ACCERA, INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. COGNITION THERAPEUTICS, INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. BIOGEN
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. F. HOFFMANN-LA ROCHE LTD
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. AMARANTUS BIOSCIENCE HOLDINGS, INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. Abbvie Inc.
2. TauRx Pharmaceuticals Ltd
3. Eli Lilly and Company.
4. Alector, Inc.
5. Treventis Corporation.
6. Accera, Inc.
7. Cognition Therapeutics, Inc.
8. Biogen
9. F. Hoffmann-La Roche Ltd
10. Amarantus BioScience Holdings, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For